Livzon Pharmaceutical to hold EGM on December 10 for board changes

Livzon Pharmaceutical Group has announced its first extraordinary general meeting of shareholders for 2025, scheduled for December 10, 2025. The meeting will be held through on-site and network voting. Shareholders will vote on proposals including the cancellation of the supervisory board, amendments to the company's articles of association, and revisions to the rules of procedure for both the general meeting and the board of directors.

A central agenda item is the election of a new independent non-executive director. The board has nominated Ms. Wang Zhiyao for this position, following the resignations of current independent non-executive directors Mr. Tian Qiusheng and Mr. Huang Jinhua, whose terms expired on October 15, 2025. The company confirmed that Ms. Wang Zhiyao, who currently does not hold company shares, will ensure compliance with all regulatory requirements prior to her appointment.

The board of directors approved Ms. Wang Zhiyao's nomination and the decision to convene the extraordinary general meeting during its twenty-eighth meeting on November 10, 2025. All proposals will be put to a shareholder vote, with the independent non-executive director nomination requiring a simple majority and other significant amendments requiring a two-thirds majority.